for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Serum Institute To Resume Trials Of Oxford-AstraZeneca COVID-19 Vaccine - PTI Report In Times Of India

Sept 16 (Reuters) -

* SERUM INSTITUTE GETS INDIAN REGULATORY APPROVAL TO RESUME TRIALS OF OXFORD-ASTRAZENECA COVID-19 VACCINE - PTI REPORT IN TIMES OF INDIA Source text: (bit.ly/2ZIt058) Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up